Secondary Logo

April 2019 - Volume 25 - Issue 3

  • Graciela S. Alarcón, MD, MPH, MACR
  • 1076-1608
  • 1536-7355
  • 8 issues / year
  • Rheumatology 23/30
  • 1.974

Current Issue Highlights


Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety

Bird, Paul; Bensen, William; El-Zorkany, Bassel; More

JCR: Journal of Clinical Rheumatology. 25(3):115-126, April 2019.